These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 626085)

  • 21. [Effect of salbutamol, indomethacin and atenolol on plasma renin activity in patients with essential arterial hypertension].
    Stornello M; Di Rao G; Iachello M; Bosco V; Pantano S; Pisani R; Scapellato L
    Minerva Nefrol; 1982; 29(3):159-64. PubMed ID: 6292792
    [No Abstract]   [Full Text] [Related]  

  • 22. Insulin-induced renin release: blockade by indomethacin in the rat.
    Campbell WB; Zimmer JA
    Clin Sci (Lond); 1980 May; 58(5):415-8. PubMed ID: 6993088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered renal prostaglandin production after sodium loading in hypertensive patients.
    Neri Serneri GG; Castellani S; Scarti L; Trotta F; Sciagrà R; Masotti G
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():203-8. PubMed ID: 3159204
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of antihypertensive drugs on plasma renin activity and urinary excretion of prostaglandin E2.
    Blum M; Algueti A; Bauminger S; Aviram A; Ayalon D
    Prostaglandins Med; 1981 Oct; 7(4):261-6. PubMed ID: 7031725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandins and plasma renin activity in hypertensive patients.
    Hornych A; London G; Safar M; Weiss Y; Simon A; Guyene TT; Bariéty J; Milliez P
    Adv Prostaglandin Thromboxane Res; 1980; 7():1119-22. PubMed ID: 6989180
    [No Abstract]   [Full Text] [Related]  

  • 26. Hypotensive and natriuretic effects of nifedipine in essential hypertension. Role of renal kallikrein-kinin-prostaglandin and renin-angiotensin-aldosterone systems.
    Tsunoda K; Abe K; Omata K; Kudo K; Sato M; Kohzuki M; Tanno M; Seino M; Yasujima M; Yoshinaga K
    J Clin Hypertens; 1986 Sep; 2(3):263-70. PubMed ID: 3640807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal prostaglandin E in sustained severe hypertension.
    Hsieh BS; Wang TC; Kuo YM; Wu KD; Yen TS; Tsai TJ; Chen WY
    Taiwan Yi Xue Hui Za Zhi; 1986 Apr; 85(4):329-34. PubMed ID: 3528387
    [No Abstract]   [Full Text] [Related]  

  • 28. Prostaglandin suppression: inability to correct severe idiopathic orthostatic hypotension.
    Crook JE; Robertson D; Whorton AR
    South Med J; 1981 Mar; 74(3):318-20. PubMed ID: 7013082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Renal prostaglandins in patients with primary arterial hypertension].
    Ignatowska-Switalska H
    Pol Arch Med Wewn; 1984 Oct; 72(4):159-66. PubMed ID: 6597408
    [No Abstract]   [Full Text] [Related]  

  • 30. Prostaglandins and the renal antihypertensive function.
    Lee JB; Düsing R
    Compr Ther; 1977 May; 3(5):25-33. PubMed ID: 862384
    [No Abstract]   [Full Text] [Related]  

  • 31. [Restructuring of the endocrine function of the kidney in hypertension].
    Nekrasova AA
    Kardiologiia; 1981 Jul; 21(7):13-20. PubMed ID: 7024615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Catecholamines, prostaglandins and intracellular electrolyte levels in patients with hypertension and low plasma renin activity].
    Wocial B; Jabłońska-Skwiecińska E; Chodakowska J; Feltynowski T; Ignatowska-Switalska H; Pawłowski W; Chojnowski K; Januszewicz W
    Kardiol Pol; 1987; 30(9):545-54. PubMed ID: 3320452
    [No Abstract]   [Full Text] [Related]  

  • 33. Indomethacin (IND) inhibits an enhanced renin release following the captopril, SQ 14225, administration.
    Abe K; Itoh T; Satoh M; Haruyama T; Imai Y; Goto T; Satoh K; Otsuka Y; Yoshinaga K
    Life Sci; 1980 Feb; 26(7):561-5. PubMed ID: 6988657
    [No Abstract]   [Full Text] [Related]  

  • 34. Correction of increased prostacyclin production in Bartter's syndrome by indomethacin.
    Güllner HG; Cerletti C; Bartter FC; Gill JR; Smith JB
    Trans Assoc Am Physicians; 1980; 93():130-40. PubMed ID: 7018063
    [No Abstract]   [Full Text] [Related]  

  • 35. [Reduced urinary prostaglandin E2-excretion and diminished responsiveness of plasma renin activity in patients with essential hypertension (author's transl)].
    Scherer B; Held E; Lange HH; Weber PC
    Klin Wochenschr; 1979 Jun; 57(11):567-73. PubMed ID: 459371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The renal prostaglandin system in central diabetes insipidus: effects of desamino-arginine vasopressin.
    Düsing R; Herrmann R; Kramer HJ
    Adv Prostaglandin Thromboxane Res; 1980; 7():1111-3. PubMed ID: 6245565
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of indomethacin on active and inactive renin in sodium-replete men at rest and during exercise.
    Lijnen P; Groeseneken D; Fagard R; Staessen J; Amery A
    J Lab Clin Med; 1984 May; 103(5):677-83. PubMed ID: 6425442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of furosemide on renal prostaglandins E2 and F2 alpha in normal subjects and in patients with essential hypertension.
    Rathaus M; Bauminger S; Bernheim J
    Isr J Med Sci; 1980 Feb; 16(2):106-10. PubMed ID: 7364563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of intrarenal vasoactive substances in the pathogenesis of essential hypertension.
    Abe K; Yasujima M; Irokawa N; Seino M; Chiba S; Sakurai Y; Sato M; Imai Y; Saito K; Ito T; Haruyama T; Otsuka Y; Yoshinaga K
    Clin Sci Mol Med Suppl; 1978 Dec; 4():363s-366s. PubMed ID: 282087
    [No Abstract]   [Full Text] [Related]  

  • 40. [Characteristics of the water-electrolyte metabolism of hypertension patients with stable hypertension and the principles of diuretic therapy].
    Nekrasova AA; Suvorov IuI; Chernova NA; Zharova EA; Nesterova AL
    Kardiologiia; 1986 Jan; 26(1):27-34. PubMed ID: 3512896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.